Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder
Crossref DOI link: https://doi.org/10.1007/s40263-017-0468-2
Published Online: 2017-10-04
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Newcorn, Jeffrey H. https://orcid.org/0000-0001-8993-9337
Nagy, Peter
Childress, Ann C.
Frick, Glen
Yan, Brian
Pliszka, Steven
Funding for this research was provided by:
Shire Development LLC
License valid from 2017-10-04